Massachusetts General Hospital Cancer Center


Beatriz Riordan a nearly 20-year survivor of Pancreatic Cancer and one of the first patients to undergo whipple procedure at Massachusetts General Hospital, discusses her care under the skillful hands of Dr. Andrew Warshaw.

Fore more information on pancreatic cancer and treatment options visit:


Massachusetts General Hospital gynecologic cancer research program director Michael Birrer, MD, PhD, explains how ovarian tumor discoveries in the lab are already impacting patient care. Instead of classifying tumors by where they are found inside the body -- as breast, lung or ovarian cancer -- researchers and clinicians are increasingly identifying cancers by their genetic signatures. With new insight into the biology of tumors, physicians can target cancer at the molecular level using smart drugs designed to attack tumor weaknesses. This strategy has proven effective for treating patients with various cancers, including those with advanced lung cancer and melanoma. Now, Mass General Cancer Center physician-scientists are applying those same principles to gynecologic oncology, redefining the way they view ovarian cancer. To learn more about innovative ovarian cancer treatments at MGH visit: To see a list of open clinical


Pancreatic cancer patients at the Massachusetts General Hospital Cancer Center benefit from the innovative work of The Andrew L. Warshaw Institute for Pancreatic Cancer Research which includes a community of scientists, oncologists, surgeons, radiation oncologists and interventional endoscopists whose mission is to extend and improve the lives of patients with pancreatic cancer. More information visit:


On July 29, a film crew working on the 2010 Stand Up To Cancer program. Featuring celebrities, rock stars, comedians, Stand Up To Cancer aims to update viewers on the latest innovations in cancer research. For more info visit:


Linnea Duff and Greg Vrettos never smoked a day in their lives, yet both were diagnosed at a young age with stage 4, inoperable lung cancer. Today, with targeted therapy their cancer has disappeared and they continue to live full active lives in the company of friends and family.

By studying the genetic profile of lung cancer tumors, researchers at Massachusetts General Hospital have made ground breaking progress in the treatment of this challenging disease. For information on genetic fingerprinting of cancer tumors, please visit:


In 2012, Dr. Mo Motamedi, an assistant professor at Harvard Medical School and an assistant geneticist at MGH Cancer Center, received a V Scholar grant. Dr. Leif Ellisen, associate professor at MGH and Harvard Medical School, was awarded a Translational grant from the V Foundation. Hear their stories in this new #PassTheV video!


When diagnosed with pancreatic cancer, avid marathoner Rich Pildis began the race of his life. At the direction of friends and family, he sought care from Dr. Andrew Warshaw of Massachusetts General Hospital who performed a whipple procedure, helping Rich get back to running and beating cancer to the finish line.

For more information on pancreatic cancer and treatment options including the whipple procedure, visit:


At the Massachusetts General Hospital Cancer Center, we are pioneering efforts to match smart drugs to a cancer's specific genetic mutation — to slow the cancer's growth — and in some cases, reduce it significantly. We know that our patients are unique and so are their tumors. Now their treatment can be, too.

For more info, or to see if you qualify for a clinical trial visit: